Short Term Atorvastatin Regime for Vasculopathic Surgical (STAR-VaS) Patients Study.
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2015
At a glance
- Drugs Atorvastatin (Primary)
- Indications Myocardial ischaemia
- Focus Pharmacodynamics
- Acronyms STAR-VaS
- 07 Jun 2017 Biomarkers information updated
- 24 Oct 2011 Planned end date changed from 1 Aug 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 20 Mar 2010 Planned end date changed from Dec 2010 to Aug 2010 as reported by ClinicalTrials.gov.